| Name | CPD-1224 |
|---|
| Description | CPD-1224 is an orally active derivative of ALK inhibitors to cereblon ligands. CPD-1224 targets to EML4-ALK oncogenic fusions, and degrades ALK and mutant L1196M/G1202R[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C43H47ClN8O7S |
|---|---|
| Molecular Weight | 855.40 |